Arcutis Biotherapeutics, Inc. ARQT Business Segments — Total revenues
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s business segments — total revenues.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s business segments — total revenues?
- Arcutis Biotherapeutics, Inc. (ARQT) reported business segments — total revenues of $105.4M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s business segments — total revenues changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s business segments — total revenues increased by 60.1% year-over-year, from $65.85M to $105.4M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s business segments — total revenues?
- Over 3 years (2022 to 2025), Arcutis Biotherapeutics, Inc.'s business segments — total revenues has grown at a 367.3% compound annual growth rate (CAGR), from $3.69M to $376.07M.
- What does business segments — total revenues mean?
- Represents the total gross income generated by the reportable business segment from its primary commercial activities. This metric reflects the market adoption and sales performance of the segment's product portfolio within the dermatology sector.